David L. Eaton

Washington State Department of Health — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

55h-index13.7kcitations230works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genomics, phytochemicals, and oxidative stress(41), Glutathione Transferases and Polymorphisms(39), Carcinogens and Genotoxicity Assessment(37), Mycotoxins in Agriculture and Food(32), Pharmacogenetics and Drug Metabolism(24)

Publications230 total

Editorial: Introduction to the Toxins Special Edition Honoring Dr. John D. Groopman for His Contributions to the Field of Aflatoxin Carcinogenesis Research
Toxins·2026Open Access
Thomas W. Kensler (1948–2025): A Legend in Antioxidant Response Pathways and Aflatoxin Carcinogenesis Research
Toxins·2025Open Access
ToxPoint: Chemical risks and children’s health—building on progress based on science, not panic
Toxicological Sciences·2025· 1 citedOpen Access
Species Differences in the Biotransformation of Aflatoxin B1: Primary Determinants of Relative Carcinogenic Potency in Different Animal Species
Toxins·2025· 22 citedOpen Access
65 Years on—Aflatoxin Biomarkers Blossoming: Whither Next?
Toxins·2024· 14 citedOpen Access
Species- and Diet-Related Differences in Aflatoxin Biotransformation
2024· 6 cited
Are humans REALLY just big rats and mice? Using the mode of action of aflatoxins, nitrosamines and dioxin-like chemicals for more relevant human-based risk assessments
Toxicology Letters·2024
Species differences in specific ligand-binding affinity and activation of AHR: The biological basis for calculation of relative effective potencies and toxic equivalence factors
Regulatory Toxicology and Pharmacology·2024· 7 cited
The 2022 revised WHO TEFs for dioxins and dioxin-like chemicals: The importance of considering the use of species-specific information to determine relative effective potency for human-based risk assessment
Regulatory Toxicology and Pharmacology·2024· 1 cited
Risk characterization of N-nitrosodimethylamine in pharmaceuticals
Food and Chemical Toxicology·2024· 11 cited
General Overview of Toxicology
Elsevier eBooks·2024· 1 cited
Biotransformation
Patty's Toxicology·2023
The Risk Assessment–Risk Management Paradigm
2022· 1 cited
Early development of multifilament polyacrylonitrile-derived structural hollow carbon fibers from a segmented arc spinneret
Carbon·2021· 8 citedOpen Access
This is your teen brain on drugs: In search of biological factors unique to dependence toxicity in adolescence
Neurotoxicology and Teratology·2020· 22 cited
Public Health Consequences of e-Cigarette Use
JAMA Internal Medicine·2018· 558 cited
Injuries and Poisonings
2018
Modes of Action
2018
Research Needs: E-Cigarette Devices, Constituents, and Exposures
2018
Section II: Effects of E-Cigarettes on Health
2018
page 1 of 12Next →

Frequent Co-authors

Theo K. Bammler(6), Evan P. Gallagher(5), Patricia L. Stapleton(5), Timo M. Buetler(4), John E. Anthony(3), Lucio G. Costa(3), Kent L. Kunze(3), Valle Nazar‐Stewart(3), Samir N. Kelada(3), Kerstin Groß‐Steinmeyer(3), Howard S. Ramsdell(3), Thomas L. Vaughan(3), Harvey Checkoway(3), Sean Parkin(2), John D. Groopman(2), Curtis D. Klaassen(2), Kenneth E. Thummel(2), Danny D. Shen(2), Edward J. Kelly(2), Arno G. Motulsky(2)